Albany, NY -- (SBWIRE) -- 12/30/2014 -- Mouth ulcers are lesions inside the mouth, occurring in up to 60% of the population in some parts of the world. These are painful but benign and non-contagious. If left alone, they heal in about three weeks. If they persist beyond that period, medical attention is necessary. The easy availability of ulcer remedies and the rising prevalence of the disease have resulted in a boom for the mouth ulcers treatment market.

Browse Mouth Ulcers Treatment Market Report with Full TOC at http://www.transparencymarketresearch.com/mouth-ulcers-treatment.html

Segmentation of the Mouth Ulcers Treatment Market

Mouth ulcer treatments are divided into four categories according to the nature or formulation of the remedy: mouthwash, gel, spray, and lozenge. As of 2013, gels are the preferred form of remedy, and are also endorsed by medical practitioners, due to their common occurrence in medical stores. Lozenges are expected to grow at the highest rate during the forecast period of 2014-2020. Their low cost, ease in packing and transport, and easy availability make them highly attractive.

Mouth ulcer treatments are categorized into five types according to the type of drug used in them: corticosteroid, anesthetic, analgesic, antimicrobial, and antihistamine. Corticosteroids are the dominant type of drug used, since they function well as both painkillers and healers. They can also be distributed in all four types of formulations: mouthwash, gel, spray, or lozenge. This makes them the first choice while treating mouth ulcers.

The global mouth ulcers treatment market is divided into four geographical sections: North America, Europe, Asia Pacific, and Rest of World. North America is the leader in the mouth ulcers treatment market, with Europe following closely behind. However, Asia Pacific, with growing amounts of income in its developing countries, is expected to grow at the highest CAGR during the forecast period.

Request for customization of this report http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2747

Mouth ulcers are also divided into three categories according to how they are manifested: aphthous stomatitis, oral lichen planus, and others. The former is the dominant category in this division, and is expected to spread at a high rate; in a 2013 study, 51% Asians were found to have been diagnosed with recurrent aphthous stomatitis.

Drivers and Restraints of the Mouth Ulcers Treatment Market

The primary driver of the mouth ulcers treatment market is the prevalence of mouth ulcers. These ulcers are a lifestyle disease and are an inevitable consequence of the modern lifestyle. As the disease expands, so does its treatment.

Lozenges will go on to become the major market segment in mouth ulcer treatment thanks to the ease of its use, its low cost, and easy availability in the growing Asia Pacific market. Many pharmaceutical companies have newly entered the lozenge market, such as Blistex Inc. with its lozenge Kank-A, due to its high potential for growth. Anesthetic, analgesic, and corticosteroidal mouth ulcer treatments are popular in the form of lozenges.

North America and Europe lead the way in mouth ulcer treatments thanks to the presence of widespread medical facilities in the region, but Asia Pacific, thanks to quickly developing economies such as India, China, Japan, and South Korea, is on its way to challenge the Western countries. The geriatric demographic in Europe is an important segment in the mouth ulcers treatment market, since it is one of the highest users of the same.

Corticosteroids, the major form of drug used to treat mouth ulcers, have one significant drawback: They can't be used for oral ulcer treatment in children, since steroids can cause numerous adverse side effects on their developing constitution. But due to the prevalence of mouth ulcers in adults, corticosteroids are and will remain the main type of drug used in ulcer treatment.

Major Players in the Mouth Ulcers Treatment Market

The market is comprised of companies such as 3M Healthcare, Bristol Meyer Squibb Company, ECR Pharmaceuticals, and Church & Dwight Co, Inc. Valued in 2013 at US$1,242.6 million, the global mouth ulcers treatment market is expected to reach an approximate value of US$1,596.9 million in 2020, growing at a CAGR of 3.8% from 2014 to 2020.

Browse all Pharmaceutical Research report http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html

About Transparency Market Research
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact
Sheela AK
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com